Research and reports

This report was commissioned by Medicines New Zealand and reviews the public funding of highly innovative modern medicines across eight key therapy areas including cancer, and compares medicine reimbursement within 20 OECD countries between 2011-2017 inclusive.

Download


Overview of the treatment of CLL

Chronic lymphocytic leukemia (CLL) is one of the chronic lymphoproliferative disorders (lymphoid neoplasms). It is characterized by a progressive accumulation of functionally incompetent lymphocytes, which are usually monoclonal in origin.

Read more


Clinical features and diagnosis of CLL/small lymphocytic lymphoma

Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is a mature B cell neoplasm characterized by a progressive accumulation of monoclonal B lymphocytes.

Read more


Overview of the complications of CLL

Chronic lymphocytic leukemia (CLL) is characterized by the progressive accumulation of usually monoclonal, functionally incompetent lymphocytes. Patients with CLL commonly develop complications associated with the intrinsic immune dysfunction that results in immunodeficiency and the development of autoimmune disorders.

Read more


Staging and prognosis of CLL

Chronic lymphocytic leukemia (CLL) is one of the B cell chronic lymphoproliferative disorders (lymphoid neoplasms). According to the World Health Organization classification, B cell CLL is considered to be identical (ie, one disease with different manifestations) to the mature (peripheral) B cell neoplasm small lymphocytic lymphoma...

Read more


Selection of initial therapy for symptomatic or advanced CLL

Chronic lymphocytic leukemia (CLL) is one of the chronic lymphoproliferative disorders (lymphoid neoplasms). It is characterized by a progressive accumulation of functionally incompetent B lymphocytes, which are usually monoclonal in origin.

Read more


Treatment of relapsed or refractory CLL

Chronic lymphocytic leukemia (CLL) is one of the chronic lymphoproliferative disorders (lymphoid neoplasms). It is characterized by a progressive accumulation of functionally incompetent lymphocytes, which are usually monoclonal in origin.

Read more